194 related articles for article (PubMed ID: 32842062)
1. The Role of Multiparametric Magnetic Resonance Imaging in the Study of Primary Tumor and Pelvic Lymph Node Metastasis in Stage IB1-IIA1 Cervical Cancer.
Zhang X; Dong Y; Song Q; Zhu Y; Pang H; Luo Y; Yu T; Liu F; Guo Y
J Comput Assist Tomogr; 2020; 44(5):750-758. PubMed ID: 32842062
[TBL] [Abstract][Full Text] [Related]
2. Value of MRI and diffusion-weighted imaging in diagnosing normal-sized pelvic lymph nodes metastases in patients with cervical cancer.
Song Q; Yu Y; Zhang X; Zhu Y; Luo Y; Yu T; Sun J; Liu F; Dong Y
Br J Radiol; 2022 Sep; 95(1138):20200203. PubMed ID: 33095657
[TBL] [Abstract][Full Text] [Related]
3. Application of apparent diffusion coefficient values derived from diffusion-weighted imaging for assessing different sized metastatic lymph nodes in cervical cancers.
Zhang A; Song J; Ma Z; Chen T
Acta Radiol; 2020 Jun; 61(6):848-855. PubMed ID: 31615267
[TBL] [Abstract][Full Text] [Related]
4. Quantitative kinetic parameters of primary tumor can be used to predict pelvic lymph node metastasis in early-stage cervical cancer.
Bai Z; Shi J; Yang Z; Zeng W; Hu H; Zhong J; Duan X; Wang X; Shen J
Abdom Radiol (NY); 2021 Mar; 46(3):1129-1136. PubMed ID: 32930831
[TBL] [Abstract][Full Text] [Related]
5. Assessment of pelvic lymph node metastasis in FIGO IB and IIA cervical cancer using quantitative dynamic contrast-enhanced MRI parameters.
Kim SH; Cho SH
Diagn Interv Radiol; 2020 Sep; 26(5):382-389. PubMed ID: 32673204
[TBL] [Abstract][Full Text] [Related]
6. Pre-treatment MRI minimum apparent diffusion coefficient value is a potential prognostic imaging biomarker in cervical cancer patients treated with definitive chemoradiation.
Marconi DG; Fregnani JH; Rossini RR; Netto AK; Lucchesi FR; Tsunoda AT; Kamrava M
BMC Cancer; 2016 Jul; 16():556. PubMed ID: 27469349
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of diffusion-weighted magnetic resonance imaging in discriminating between metastatic and non-metastatic pelvic lymph nodes in endometrial cancer.
Arian A; Easa AM; Arab-Ahmadi M
Acta Radiol; 2020 Nov; 61(11):1580-1586. PubMed ID: 32106683
[TBL] [Abstract][Full Text] [Related]
8. Distinguishing mesorectal tumor deposits from metastatic lymph nodes by using diffusion-weighted and dynamic contrast-enhanced magnetic resonance imaging in rectal cancer.
Xu Q; Xu Y; Wang J; Sun H; Lin J; Xie S
Eur Radiol; 2023 Jun; 33(6):4127-4137. PubMed ID: 36520180
[TBL] [Abstract][Full Text] [Related]
9. [Value of diffusion-weighted imaging in diagnosis of lymph node metastasis in patients with cervical cancer].
Zhang J; Ren C; Xue HD; Zhou HL; Sun ZY; Jin ZY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2014 Feb; 36(1):73-8. PubMed ID: 24581133
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the diagnostic performance of apparent diffusion coefficient (ADC) values on diffusion-weighted magnetic resonance imaging (DWI) in differentiating between benign and metastatic lymph nodes in cases of cholangiocarcinoma.
Promsorn J; Soontrapa W; Somsap K; Chamadol N; Limpawattana P; Harisinghani M
Abdom Radiol (NY); 2019 Feb; 44(2):473-481. PubMed ID: 30151713
[TBL] [Abstract][Full Text] [Related]
11. Feasibility of Predicting Pelvic Lymph Node Metastasis Based on IVIM-DWI and Texture Parameters of the Primary Lesion and Lymph Nodes in Patients with Cervical Cancer.
Zhang Y; Zhang KY; Jia HD; Fang X; Lin TT; Wei C; Qian LT; Dong JN
Acad Radiol; 2022 Jul; 29(7):1048-1057. PubMed ID: 34654623
[TBL] [Abstract][Full Text] [Related]
12. Improving lymph node characterization in staging malignant lymphoma using first-order ADC texture analysis from whole-body diffusion-weighted MRI.
De Paepe KN; De Keyzer F; Wolter P; Bechter O; Dierickx D; Janssens A; Verhoef G; Oyen R; Vandecaveye V
J Magn Reson Imaging; 2018 Oct; 48(4):897-906. PubMed ID: 29656584
[TBL] [Abstract][Full Text] [Related]
13. Combining tumor size and diffusion-weighted imaging to diagnose normal-sized metastatic pelvic lymph nodes in cervical cancers.
Song J; Hu Q; Huang J; Ma Z; Chen T
Acta Radiol; 2019 Mar; 60(3):388-395. PubMed ID: 29911401
[TBL] [Abstract][Full Text] [Related]
14. Radiomics Analysis of Multiparametric MRI Evaluates the Pathological Features of Cervical Squamous Cell Carcinoma.
Wu Q; Shi D; Dou S; Shi L; Liu M; Dong L; Chang X; Wang M
J Magn Reson Imaging; 2019 Apr; 49(4):1141-1148. PubMed ID: 30230114
[TBL] [Abstract][Full Text] [Related]
15. Application of Dynamic Enhanced Magnetic Resonance Imaging Texture Analysis Combined with ADCs in Predicting Pelvic Lymph Metastasis of Prostate Cancer.
Yao L; Ding J; Li X; Yang J; Chen Z; Jia C; Duan Q
Arch Esp Urol; 2023 Aug; 76(6):383-388. PubMed ID: 37681328
[TBL] [Abstract][Full Text] [Related]
16. 99mTc-Nanocolloid SPECT/MRI Fusion for the Selective Assessment of Nonenlarged Sentinel Lymph Nodes in Patients with Early-Stage Cervical Cancer.
Hoogendam JP; Zweemer RP; Hobbelink MG; van den Bosch MA; Verheijen RH; Veldhuis WB
J Nucl Med; 2016 Apr; 57(4):551-6. PubMed ID: 26678614
[TBL] [Abstract][Full Text] [Related]
17. Combinative evaluation of primary tumor and lymph nodes in predicting pelvic lymphatic metastasis in early-stage cervical cancer: A multiparametric PET-CT study.
Li K; Sun H; Guo Q
Eur J Radiol; 2019 Apr; 113():153-157. PubMed ID: 30927941
[TBL] [Abstract][Full Text] [Related]
18. Combined dynamic contrast enhanced MRI parameter with clinical factors predict the survival of concurrent chemo-radiotherapy in patients with 2018 FIGO IIICr stage cervical cancer.
Qin F; Pang H; Ma J; Zhao M; Jiang X; Tong R; Yu T; Luo Y; Dong Y
Eur J Radiol; 2021 Aug; 141():109787. PubMed ID: 34051683
[TBL] [Abstract][Full Text] [Related]
19. Histogram analysis of apparent diffusion coefficients for predicting pelvic lymph node metastasis in patients with uterine cervical cancer.
Lee J; Kim CK; Park SY
MAGMA; 2020 Apr; 33(2):283-292. PubMed ID: 31549269
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis of lymph node metastasis on rectal cancer by PET-CT computer imaging combined with MRI technology.
Li F; Hu J; Jiang H; Sun Y
J Infect Public Health; 2020 Sep; 13(9):1347-1353. PubMed ID: 31289005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
